Tumor evasion from T cell surveillance. - Wikidata - awgldk - TriplyDB

Tumor evasion from T cell surveillance.

Tumor evasion from T cell surveillance.

http://www.wikidata.org/entity/Q37970674

about

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.If It's Not One Thing, It's Another: An Inverse Relationship of Malignancy and Atherosclerotic Disease.Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110 Microenvironment abnormalities and lymphomagenesis: Immunological aspects.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.Mechanism of immune evasion in breast cancer.siRNA and cancer immunotherapy.Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Cancer immunotherapy using tumor cryoablation.Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny.Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells.The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer.Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts.Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition.Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells.The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP.Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.Preclinical and clinical advances in transposon-based gene therapy.Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.The Role of Tumor Microenvironment in Cancer Immunotherapy.Reconstruction of kidney renal clear cell carcinoma evolution across pathological stages.MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.Chimeric antigen receptor-engineered primary natural killer cells: a tool to improve adoptive tumor immunotherapy.Apoptosis-Mediated Chemoprevention by Different Ratios of Fish Oil in Experimental Colon Carcinogenesis.Immunotherapeutic interventions of Triple Negative Breast Cancer.Checkpoint inhibitor-associated cutaneous small vessel vasculitis

P2860

Q26750579-C1CF8701-E1A3-45A8-A5D6-6A675055448A Q26779200-1F7430E8-B9D5-4357-AA35-0FFE55CD531A Q26784043-3E61F805-31B9-4FBE-8BAC-37E39D5812B6 Q27345360-F1F139C2-F169-4E4B-8633-650BA234D5D6 Q34297618-FD104616-A64A-4B32-8BDE-D53DC4D71DFC Q35597405-526F15B2-E9B0-447D-9BA8-F0A0B2134199 Q35637017-87F0877E-BF53-4AC2-AA8E-581708B4518E Q35761001-D690446D-51A5-42F2-9DAA-D9060E91C71C Q35824663-4E8749C8-40DC-4239-9DE2-B80E48542BB1 Q36118020-AE320001-3EC7-40A5-B7A5-7ED37EA2D4C9 Q36470354-B72BBAEA-49BC-4333-9796-188F9E64EF76 Q37215829-8DBCC7CC-9586-491E-829A-01570A8620AA Q37712385-020D2AC4-CF51-4BD0-99F6-B621069DDA7A Q38050504-3EC45C62-5CE5-41A5-82EA-B8CCD00AC1AE Q38093572-9F405909-FFA1-4AE4-8DCA-2CBF2AEC2380 Q38110540-0B13C795-A64E-438A-8057-26D3D4AB8F2C Q38171573-40B57413-795E-47B6-8EDB-6886F9BADB1B Q38214095-65CC71EF-3919-408E-B368-CA83540F8221 Q38336989-77A1F632-93AD-4577-9081-90D5A44622B5 Q38684886-31F179F9-AE3B-42E3-80F8-C9B0B0AA2AD2 Q38752357-AE8FD978-7DD5-4809-BE7C-A8D4E1814A07 Q38994510-36716271-FE0F-4B33-8CF8-E0075C75CDFD Q39312378-2DAFFE3A-74B7-4EA5-8B6E-41DD10B41A06 Q40759062-2C48BA91-2C34-4C4B-B7DE-F8D7948D8ABF Q41085306-BFBC93D7-E416-4932-AA10-2806DD3DD3B2 Q41367801-FA772917-0D8B-4936-807F-2B4BCDDD5945 Q41660817-C2A7C8C2-2360-4DAF-86B8-7F4EF24C9B2E Q42670239-7FB7CA4C-1D50-4C9E-B919-DCCE5C69DACD Q42925679-551CD5CC-4762-4CFF-9729-A8C483436EF4 Q43100151-D0ACF025-136F-4C03-B75D-022A6E772771 Q43878420-52057D26-78F9-46B0-8660-FE4F4BC31A18 Q45873802-9E4EFD74-6E2A-467D-96DE-1A7FFAE75AB5 Q46758501-3954BFE6-DFF8-4B80-9665-51FC27D2CE55 Q47252754-B07E84D0-29E4-4639-A0E6-F5CE2F8089A2 Q49789459-AB43D8E2-3272-474C-BF79-71FCBA3073B4 Q50117508-9E1CAF16-5304-464C-B134-3682E106F014 Q51219083-0B8D5F76-6995-4C8B-A3A9-5E779A0A9B55 Q53098952-5E3BDD7B-8262-4E12-BEE2-03AE8D4C4A23 Q55257180-49440CE1-89CF-4736-899D-43AAAEDA406A Q56890171-C5388F47-6FCD-446A-AD37-C9A878921C8D

P2860

Tumor evasion from T cell surveillance.

http://www.wikidata.org/entity/Q37970674

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Tumor evasion from T cell surveillance.

@en

Tumor evasion from T cell surveillance.

@nl

type

label

Tumor evasion from T cell surveillance.

@en

Tumor evasion from T cell surveillance.

@nl

prefLabel

Tumor evasion from T cell surveillance.

@en

Tumor evasion from T cell surveillance.

@nl

P1433

Q37970674-6B6DA621-6971-408E-9791-E5F6CEDA7523

P1476

Q37970674-BD07F93D-98AA-48D2-B43B-758DAF67AEAC

P2093

Q37970674-0C23FF24-1BB0-4459-9601-0F6E3FBB73E2

Q37970674-29EDCC14-E58B-4EA9-8979-8F67E77CCDA2

Q37970674-9AE94CDF-9271-4843-A9F8-88A1E5699716

Q37970674-A7497A60-0000-4A91-8EA8-82C7861B44B4

Q37970674-ACE76442-F653-4A56-9333-C3ACA8957892

Q37970674-C2743F91-829A-45A0-A26F-F2D177E829FE

P2860

Q37970674-01C5EB5B-ABA4-4F20-8B54-656226BCC1FE

Q37970674-02BB8CBB-3B29-4098-9905-93BAA44D0E95

Q37970674-0833CC03-3588-4685-9E25-321E92827126

Q37970674-0AFA8443-C240-4EB5-834C-5BF6F7B77255

Q37970674-0BE96061-AE98-46D2-9DCA-9A2F0B794DDA

Q37970674-0C331714-E6F8-4456-9CAE-F63763D78DC8

Q37970674-0D71751B-0719-4E26-B438-05A0B2A8894B

Q37970674-0D904B1E-09C9-4699-94AF-14F69D44520F

Q37970674-0E2792C1-5238-4FCA-9CAB-F317838CA11E

Q37970674-0F578630-0062-4A36-BF5E-C239744C05BD

P304

Q37970674-B5D369A5-55F4-4A05-BACA-7C88B2640F87

P31

Q37970674-BCA09685-CC8B-43DA-AD29-BE341C9D6122

Q37970674-E0D988B2-13AC-4904-A2B2-49ED0519B276

P356

Q37970674-C75333A7-0F34-4B9A-81CF-DB61937CD352

P478

Q37970674-98A37383-EE72-42EE-841B-7120A08697A9

P50

Q37970674-2E8DCB4B-CFCC-4CD9-9028-D736879A93EA

Q37970674-DE832260-146D-4876-ABF3-E0123C416CA6

P577

Q37970674-23748C10-384B-41FA-910A-3B8E01812E88

P5875

Q37970674-5E2BF994-D344-4D65-BE18-A3D057D7339C

P698

Q37970674-3A86A8BD-7256-4A0C-8FA3-9CCA98CA1AD1

P921

Q37970674-4280ADAF-FB85-4D24-A013-393E0C6289D6

Q37970674-89BC5B61-E2FF-4FCA-BD60-20F6F45FA531

Q37970674-9C95B3AC-11B9-43D9-8C97-C2C1C6042775

P932

Q37970674-82131118-7AC0-4D40-9AC7-3785F29AD017

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

Tumor evasion from T cell surveillance.

@en

P2093

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Katrin Töpfer

http://www.w3.org/2001/XMLSchema#string

Marc Cartellieri

http://www.w3.org/2001/XMLSchema#string

Marc Schmitz

http://www.w3.org/2001/XMLSchema#string

Nadja Müller

http://www.w3.org/2001/XMLSchema#string

Stefanie Kempe

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

Interleukin-10 and the interleukin-10 receptor

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

Prevention of allogeneic fetal rejection by tryptophan catabolism

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

P304

918471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/918471

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

Michael Bachmann

P577

2011-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51904722

http://www.w3.org/2001/XMLSchema#string

P698

22190859

http://www.w3.org/2001/XMLSchema#string

P921

hemic and immune systems

P932

3228689

http://www.w3.org/2001/XMLSchema#string